SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-000589
Filing Date
2021-01-06
Accepted
2021-01-06 07:51:18
Documents
1
Period of Report
2021-01-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1539
  Complete submission text file 0001213900-21-000589.txt   3156
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Issuer) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address
Shemesh-Rasmussen Maital (Reporting) CIK: 0001838454 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31392 | Film No.: 21509022